DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA)

DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) Catalog number: BADC-01422

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) is a click-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Cytotoxin with Linkers
Product Name
DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA)
Catalog Number
BADC-01422
Molecular Formula
C79H95ClN12O20
Molecular Weight
1568.14

Ordering Information

Catalog Number Size Price Quantity
BADC-01422 -- $-- Inquiry
Description
DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) is a click-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs).
InChI
InChI=1S/C79H95ClN12O20/c1-48(2)68(88-65(94)27-32-107-34-36-109-38-39-110-37-35-108-33-29-82-64(93)25-26-66(95)91-45-52-16-10-9-14-50(52)21-22-51-15-11-12-18-60(51)91)74(97)87-57(17-13-28-83-77(81)100)73(96)84-55-23-19-49(20-24-55)47-111-78(101)89(3)30-31-90(4)79(102)112-62-43-61-67(56-42-59(76(99)106-8)86-70(56)62)54(44-80)46-92(61)75(98)58-40-53-41-63(103-5)71(104-6)72(105-7)69(53)85-58/h9-12,14-16,18-20,23-24,40-43,48,54,57,68,85-86H,13,17,25-39,44-47H2,1-8H3,(H,82,93)(H,84,96)(H,87,97)(H,88,94)(H3,81,83,100)/t54-,57+,68+/m1/s1
InChIKey
LRCRYXKCKKVMDA-CJHYWFRCSA-N

DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) is a complex molecule used in targeted drug delivery and cancer therapy. Here are some key applications of DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA):

Antibody-Drug Conjugates (ADCs): This compound is utilized in the design of ADCs, which are engineered to target and destroy cancer cells specifically. The DBCO group enables site-specific conjugation to antibodies, ensuring precise delivery of the cytotoxic payload. By selectively targeting cancer cells, ADCs minimize off-target effects and improve the therapeutic index.

Cellular Imaging: DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) can be used in cellular imaging applications to study cell surface proteins and internalization mechanisms. The DBCO moiety reacts with azide-modified biomolecules in a bioorthogonal fashion, allowing for the visualization of molecular interactions. This helps researchers to track the localization and fate of the compound within living cells.

Drug Delivery Systems: This molecule is fundamental in developing advanced drug delivery systems such as polymeric nanoparticles and liposomes. The PEG4 spacer improves solubility and biocompatibility, while the cleavable VC-PAB linker ensures the controlled release of the active drug within the target cells. This enhances the efficacy and safety profile of nanoparticle-based therapeutics.

Cancer Therapeutics Research: DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) is widely used in preclinical research to explore new cancer therapeutic strategies. By studying the pharmacodynamics and pharmacokinetics of this compound, researchers can optimize its design for better targeting and reduced toxicity. This accelerates the development of next-generation cancer therapies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket